These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26022999)

  • 1. Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients.
    Johnson NE; Arnold WD; Hebert D; Gwathmey K; Dimachkie MM; Barohn RJ; McVey AL; Pasnoor M; Amato AA; McDermott MP; Kissel J; Heatwole CR
    Neuromuscul Disord; 2015 Aug; 25(8):625-31. PubMed ID: 26022999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab as therapy for refractory polymyositis and dermatomyositis.
    Noss EH; Hausner-Sypek DL; Weinblatt ME
    J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid Monotherapy Is Usually Insufficient Treatment for Idiopathic Inflammatory Myopathy.
    Mathur T; Manadan AM; Thiagarajan S; Hota B; Block JA
    Am J Ther; 2015; 22(5):350-4. PubMed ID: 23797759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of pulse intravenous methylprednisolone treatment in juvenile dermatomyositis.
    Lang B; Dooley J
    J Pediatr; 1996 Mar; 128(3):429-32. PubMed ID: 8774518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
    Ramanan AV; Campbell-Webster N; Ota S; Parker S; Tran D; Tyrrell PN; Cameron B; Spiegel L; Schneider R; Laxer RM; Silverman ED; Feldman BM
    Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
    Kasteler JS; Callen JP
    J Am Acad Dermatol; 1997 Jan; 36(1):67-71. PubMed ID: 8996263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis.
    Edge JC; Outland JD; Dempsey JR; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):65-9. PubMed ID: 16415388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strength in polymyositis and dermatomyositis: best outcome in patients treated early.
    Fafalak RG; Peterson MG; Kagen LJ
    J Rheumatol; 1994 Apr; 21(4):643-8. PubMed ID: 8035387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis.
    Oddis CV; Medsger TA
    J Rheumatol; 1988; 15(5):807-11. PubMed ID: 3172094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulse Dose Methylprednisolone Therapy for Adult Idiopathic Inflammatory Myopathy.
    Raghu P; Manadan AM; Schmukler J; Mathur T; Block JA
    Am J Ther; 2015; 22(4):244-7. PubMed ID: 25490616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dermatomyositis with subcutaneous generalized edema.
    Werner de Castro GR; Appenzeller S; Bértolo MB; Costallat LT
    Clin Rheumatol; 2006 Nov; 25(6):898-900. PubMed ID: 16308667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy.
    Huang JL
    Clin Exp Rheumatol; 1999; 17(5):621-4. PubMed ID: 10544850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory myopathies--a review of newly diagnosed patients (2004-2008) in the Counties Manukau region.
    Gupta R; Gow PJ
    N Z Med J; 2013 Mar; 126(1370):89-95. PubMed ID: 23474516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
    Adams EM; Pucino F; Yarboro C; Hicks JE; Thornton B; McGarvey C; Sonies BC; Bartlett ML; Villalba ML; Fleisher T; Plotz PH
    J Rheumatol; 1999 Feb; 26(2):352-60. PubMed ID: 9972969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients.
    Efthimiou P; Schwartzman S; Kagen LJ
    Ann Rheum Dis; 2006 Sep; 65(9):1233-6. PubMed ID: 16476710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature.
    Matsubara S; Kondo K; Sugaya K; Miyamoto K
    Clin Rheumatol; 2012 Oct; 31(10):1493-8. PubMed ID: 22886003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil in juvenile dermatomyositis: a case series.
    Dagher R; Desjonquères M; Duquesne A; Quartier P; Bader-Meunier B; Fischbach M; Guiguonis V; Picherot G; Cimaz R
    Rheumatol Int; 2012 Mar; 32(3):711-6. PubMed ID: 21152922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.